Commentaries & Insights

Our Commentaries and Insights are short-form publications intended to distill long-form research and synthesize current policymaking activity into easily understood concepts.

CFIUS and the Pace of Technological Advancement

To keep pace with evolving technology and national security concerns, the scope of the Committee on Foreign Investment in the United States (CFIUS) is expanding

How Should the Court Respond to the Combination of Political Polarity, Legislative Impotence, and Executive Branch Overreach?

Working paper examines how extreme political polarization in the U.S. contributes to degraded effectiveness at all three branches of the federal government.

Regulating Without Purpose

How do we measure success if we don’t know what we’re trying to accomplish? If we don’t know why we are spurred to action, how do we distinguish progress from h

Quantifying the Effects of Humane Society v. Department of Agriculture

This article uses data from two presidential transitions to quantify the number and types of public inspection documents that were withdrawn.

Avoiding Unduly Concentrated Clean Energy Markets

The IRS will need help to avoid unintended adverse effects in implementing the Inflation Reduction Act’s clean energy provisions.

What a Confirmation Hearing Might Reveal

Senate confirmation hearings represent an important check on presidential power: Know what to look for as the hearing unfolds.

Red Tape Literature in Public Administration

This Insight reviews an extensive public administration literature on the subject of “red tape.”

Agile Regulation for Auto Safety and Innovation

The automotive regulatory system designed decades ago offers an example of agile governance that can support both safety and innovation as technology evolves

The Trend and Fluctuations in News Attention to Regulation

Regulation has been drawing increasing media coverage in recent years alongside important regulatory developments and historical events.

Policymaking through Adjudication: DEA’s Red Flags

DEA's red flags policy has made some pharmacies reluctant to fill prescriptions for buprenorphine, a drug that can help tackle the opioid crisis.